Bita Behnava

928 total citations
57 papers, 644 citations indexed

About

Bita Behnava is a scholar working on Hepatology, Epidemiology and Hematology. According to data from OpenAlex, Bita Behnava has authored 57 papers receiving a total of 644 indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Hepatology, 48 papers in Epidemiology and 4 papers in Hematology. Recurrent topics in Bita Behnava's work include Hepatitis C virus research (53 papers), Hepatitis B Virus Studies (47 papers) and Liver Disease Diagnosis and Treatment (40 papers). Bita Behnava is often cited by papers focused on Hepatitis C virus research (53 papers), Hepatitis B Virus Studies (47 papers) and Liver Disease Diagnosis and Treatment (40 papers). Bita Behnava collaborates with scholars based in Iran, United States and Netherlands. Bita Behnava's co-authors include Seyed Moayed Alavian, Heidar Sharafi, Maryam Keshvari, Seyed Vahid Tabatabaei, Seyyed Mohammad Miri, Kamran Bagheri Lankarani, Mohammad Gholami Fesharaki, Mario Rizzetto, Hamidreza Karimi‐Sari and Ahmad Fatemi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Journal of Medical Virology.

In The Last Decade

Bita Behnava

56 papers receiving 633 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bita Behnava Iran 15 568 533 37 37 37 57 644
Maryam Keshvari Iran 14 439 0.8× 416 0.8× 29 0.8× 26 0.7× 26 0.7× 45 523
Vanessa Haynes–Williams United States 8 448 0.8× 448 0.8× 54 1.5× 17 0.5× 33 0.9× 9 561
Zu-Yau Lin Taiwan 16 607 1.1× 589 1.1× 35 0.9× 51 1.4× 7 0.2× 28 684
Julia O’Brien United Kingdom 9 399 0.7× 400 0.8× 17 0.5× 23 0.6× 19 0.5× 12 510
Joann Harvey United States 7 868 1.5× 787 1.5× 19 0.5× 93 2.5× 22 0.6× 8 911
I. Lonjon France 8 482 0.8× 495 0.9× 46 1.2× 49 1.3× 66 1.8× 9 622
Hironori Tanimoto Japan 7 350 0.6× 307 0.6× 15 0.4× 50 1.4× 13 0.4× 18 388
J.-P. Zarski France 8 650 1.1× 586 1.1× 18 0.5× 149 4.0× 35 0.9× 14 719
Giovanna Fattovich Italy 6 562 1.0× 498 0.9× 67 1.8× 18 0.5× 70 1.9× 7 670
Deyuan Jiang United States 11 534 0.9× 531 1.0× 31 0.8× 105 2.8× 32 0.9× 26 703

Countries citing papers authored by Bita Behnava

Since Specialization
Citations

This map shows the geographic impact of Bita Behnava's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bita Behnava with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bita Behnava more than expected).

Fields of papers citing papers by Bita Behnava

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bita Behnava. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bita Behnava. The network helps show where Bita Behnava may publish in the future.

Co-authorship network of co-authors of Bita Behnava

This figure shows the co-authorship network connecting the top 25 collaborators of Bita Behnava. A scholar is included among the top collaborators of Bita Behnava based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bita Behnava. Bita Behnava is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Mousavi, Sayed Hamid, et al.. (2019). First Report of Prevalence of Blood-Borne Viruses (HBV, HCV, HIV, HTLV-1 and Parvovirus B19) Among Hemophilia Patients in Afghanistan. Scientific Reports. 9(1). 7259–7259. 7 indexed citations
3.
Karimi‐Sari, Hamidreza, et al.. (2018). Acute changes in cardiac function by direct acting antiviral therapy for hepatitis C−infected patients with thalassemia. Journal of Medical Virology. 91(3). 419–427. 2 indexed citations
4.
Sharafi, Heidar, et al.. (2017). A Simple PCR-RFLP Method for Genotyping ofIFNL4rs368234815 Polymorphism in Patients With Chronic Hepatitis C. Laboratory Medicine. 48(1). 51–56. 9 indexed citations
5.
Sharafi, Heidar, et al.. (2016). Next Steps Toward Eradication of Hepatitis C in the Era of Direct Acting Antivirals. Hepatitis Monthly. 16(4). e37089–e37089. 49 indexed citations
6.
Alavian, Seyed Moayed, et al.. (2015). High Response Rate to Pegylated Interferon Alpha and Ribavirin Combination Therapy in Hemophilic Children with Chronic Hepatitis C; A Case-Control Study. Pediatric Hematology and Oncology. 32(6). 399–405. 4 indexed citations
7.
Sharafi, Heidar, et al.. (2014). The Impact of IFNL4 rs12979860 Polymorphism on Spontaneous Clearance of Hepatitis C; A Case-Control Study. Hepatitis Monthly. 14(10). e22649–e22649. 23 indexed citations
8.
Keyvani, Hossein, et al.. (2014). Distribution of Hepatitis B Virus Genotypes in Azerbaijani Patients With Chronic Hepatitis B Infection. Hepatitis Monthly. 14(12). e25105–e25105. 8 indexed citations
9.
Abbasinazari, Mohammad, Bita Behnava, Yunes Panahi, et al.. (2013). lasma Zinc Level in Hepatitis C Patients With or Without Beta Thalassemia Major; Is There Any Difference?. Hepatitis Monthly. 13(8). e11138–e11138. 8 indexed citations
10.
Alavian, Seyed Moayed, Seyed Vahid Tabatabaei, Bita Behnava, & Mario Rizzetto. (2012). Standard and pegylated interferon therapy of HDV infection: A systematic review and meta- analysis. SHILAP Revista de lepidopterología.
11.
Sharafi, Heidar, et al.. (2012). Distribution of IL28B Genotypes in Iranian Patients with Chronic Hepatitis C and Healthy Individuals. Hepatitis Monthly. 12(12). e8387–e8387. 30 indexed citations
12.
Sali, Shahnaz, et al.. (2012). Real Response to Therapy in Chronic Hepatitis C Virus Patients: A Study From Iran. Hepatitis Monthly. 12(9). e6151–e6151. 23 indexed citations
13.
Alavian, Seyed Moayed, Seyyed Mohammad Miri, Seyed Vahid Tabatabaei, et al.. (2011). Lipid Profiles and Hepatitis C Viral Markers in HCV-Infected Thalassemic Patients. Gut and Liver. 5(3). 348–355. 12 indexed citations
14.
Alavian, Seyed Moayed, Seyed Vahid Tabatabaei, Maryam Keshvari, et al.. (2010). Peginterferon α-2a and ribavirin treatment of patients with haemophilia and hepatitis C virus infection: a single-centre study of 367 cases. Liver International. 30(8). 1173–1180. 39 indexed citations
15.
Keshvari, Maryam, Seyed Moayed Alavian, Bita Behnava, et al.. (2010). Distribution of hepatitis C virus genotypes in Iranian patients with congenital bleeding disorders.. Iranian Red Crescent Medical Journal. 12(6). 608–614. 20 indexed citations
16.
Alavian, Seyed Moayed, et al.. (2008). Frequency of Fatty Liver and Some of Its Risk Factors in Asymptomatic Carriers of HBV Attending the Tehran Blood Transfusion Organization Hepatitis Clinic. Majallah-i ghudad-i darūn/rīz va mitābulīsm-i Īrān./Majallah-i ghudad-i darūn/rīz va mitābulīsm-i Īrān.. 10(238). 99–106. 5 indexed citations
17.
Behnava, Bita, et al.. (2007). What is the Reason for Poor Outcome of Antepartum Immunoprophylaxis of Hepatitis B Immunoglobulin in Prevention of Vertical Hepatitis B Transmission. Hepatitis Monthly. 7(3). 163–165. 3 indexed citations
18.
Behnava, Bita, et al.. (2006). The Prevalence of Thrombocytopenia in Patients with Chronic Hepatitis B and C. Hepatitis Monthly. 6(2). 67–69. 11 indexed citations
19.
Alavian, Seyed Moayed, et al.. (2006). Efficacy and safety of Interferon-alpha (PDferon B®) and Ribavirin Combination Therapy in patients with Chronic Hepatitis C in Iran. Hepatitis Monthly. 6(1). 11–18. 3 indexed citations
20.
Behnava, Bita, et al.. (2005). Rheumatoid Case with HCV Infection. Hepatitis Monthly. 2005(1). 7–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maryam Keshvari Breakdown of academic impact, for papers by Vanessa Haynes–Williams Breakdown of academic impact, for papers by Zu-Yau Lin Breakdown of academic impact, for papers by Julia O’Brien Breakdown of academic impact, for papers by Joann Harvey Breakdown of academic impact, for papers by I. Lonjon Breakdown of academic impact, for papers by Hironori Tanimoto Breakdown of academic impact, for papers by J.-P. Zarski Breakdown of academic impact, for papers by Giovanna Fattovich Breakdown of academic impact, for papers by Deyuan Jiang
Rankless by CCL
2026